International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 4770-4775
Research Article
Study Of Bacteriological Profile and Their Antibiotic Sensitivity Pattern in Catheter Associated Urinary Tract Infection in Patients at Tertiary Care Hospital
 ,
 ,
 ,
 ,
Received
May 17, 2026
Accepted
June 8, 2026
Published
June 30, 2026
Abstract

Introduction: Antimicrobial Resistance and Hospital Acquired Infections are the modern hazards in the field of medicine The aim of the present study was to identify uro-pathogens causing UTI in patients with indwelling catheter and to assess their antibiotic susceptibility profile in a tertiary care hospital.

Materials and Methods: The present study is hospital based cross sectional study done in tertiary care hospital. The study was done for a period of January 2021 to June 2022 and included 256 patients. who were admitted in ICU and ward required urinary catheterization. Under aseptic conditions urine samples were collected and processed in the department of Microbiology, as per standard protocols. Bacterial identification and antibiotic susceptibility testing were done by conventional bacteriological techniques.

Result: A total of 256 patients undergoing catheterization were evaluated for UTI. Culture positivity rate is marginally higher in females (36.71%) compared to males (21.87%). Culture positivity was observed in 150 (58.58%) and 106 (41.42%) were culture negative. The results of the study revealed that the most common isolate causing CAUTI in the hospital was Escherichia coli, followed by Klebsiella pneumoniae Staphylococcus aureus, Enterococci and Pseudomonas aeruginosa. Among culture positive cases, Gram negative isolate was more predominant (68.67%) and Gram positive were (30.67%) and Candida (0.66). Isolated gram-negative organisms show most sensitive to Piperacillin- tazobactam, Amikacin. Gram positive isolates were highly sensitive to Linezolid.

Discussion and Conclusion: CAUTI remained a great burden to patient safety and a challenge to the infection control team. Unnecessary urethral catheterization should be avoided to reduce catheter-related complications Urinary tract infections is the most common nosocomial infections, comprising about 35%. Adherence to infection control program and proper enforcement and periodic review of antibiotic policy well definitely reduces CAUTI thereby decreasing patient morbidity.

Keywords
INTRODUCTION

 Urinary tract infection (UTI) is a spectrum of disease caused by microbial invasion of the genitourinary tract that extends from renal cortex of the kidney to the urethral meatus1. Urinary tract infections (UTI) are among the most common bacterial infections, and affect about 150 million individuals annually worldwide. 2 Catheter acquired urinary tract infection is one of the most common healthcare acquired infections; It has been estimated that about 10% of hospitalized patients require urinary catheterization.3

 

For an infection to be classified as a CAUTI under guidelines published by the US Centers for Disease Control and Prevention (CDC), a patient must have:

  • Had an indwelling urinary catheter for more than 2 days by the date of event,
  • One sign or symptom including fever, suprapubic tenderness, costovertebral angle tenderness, urinary frequency or urgency or dysuria; and
  • Urine culture with more than 105 CFU/mL of one bacterial species (non- bacterial pathogens have been excluded since 2015).4

The duration of catheterization is directly related to the development of infection. Bacteria can easily invade the lower urinary tract along the external surface of the catheter or by ascending route through the lumen of the catheter.5 Risk factors associated with development of CAUTI include prolonged catheterization, lengthy hospital stay, female gender and co-morbid conditions.6 CAUTI can lead to complications such as prostatitis, epididymitis, and orchitis in males, and cystitis, pyelonephritis, gram-negative bacteremia, endocarditis, vertebral osteomyelitis, septic arthritis, endophthalmitis, and meningitis.7 High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections.8

 

Hence, this study was undertaken to know the microbial profile and antibiotic sensitivity pattern in patients suffering from Urinary Tract Infection.

 

Objectives

  1. To isolate the organisms causing CAUTI
  2. To study the antibiotic pattern sensitivity pattern of the isolates causing CAUTI.

 

MATERIALS AND METHOD

Type of study - It was a hospital based cross sectional study.

Study Duration: From January 2021 to June 2022 

Sample size: 256 patients (catheterised urine samples)

Study Site and Population: A hospital-based study survey among All clinically suspected cases of urinary tract infection in catheterized patients above 18 years of age admitted in wards and ICUs.

 

Inclusion Criteria:

  1. All patients catheterized for more than 48hrs at the time of specimen collection, admitted in wards and ICUs.
  2. Patients of age more than 18years.
  3. Both sexes included.

 

 Exclusion Criteria

  1. Pregnant women.
  2. Patients less than 18years of age.
  3. Patients on antimicrobial therapy for UTI.

 

Procedure methodology:

Urine samples were collected from clinically suspected cases of CAUTI in a sterile wide mouthed universal container taking aseptic precautions with a sterile disposable syringe after cleaning and clamping the catheter tube or port of Foley‘s catheter9.Macroscopic and Microscopic examination of urine was done.

 

Wet mount was prepared for microscopic examination using uncentrifuged samples, to note the number of pus cells, epithelial cells, RBCs and microorganisms in high-power magnification.10 Urine samples were subjected to cultures and complete bacteriological identification done according to standard operating procedures. The samples were then inoculated semi quantitatively on 5% sheep blood agar, Cystine Lactose Electrolyte Deficient (CLED) agar, MacConkey agar and incubated overnight at 37°C aerobically.10 After overnight incubation, colony count of the growth was performed to confirm its significance according to the Kass Concept of Significant Bacteriuria. The urine cultures of colony count >105 colony forming units (CFU)/ML with no more than two species of microorganisms were considered as positive for CAUTI and cultures showing growth of more than two types of bacteria were considered contaminated. The plates with significant colony count were further processed based on colony morphology, Gram staining and standard biochemical tests for species level identification of bacteria were done. Antibiotic susceptibility testing was performed by Kirby-Bauer s disk diffusion method on Mueller-Hinton agar as per the CLSI guidelines.11

 

RESULTS AND OBSERVATIONS-

The incidence of CAUTI in our study was found to be 58.58%.

A total of 256 samples were included in the study among which 160 were females and 96 were males below are the results and observations of the study undertaken-

 

Table No.1- Gender Distribution

Gender

Percentage

Female

63 %

Male

37 %

In our study the majority of the samples were collected from female patients (63%), the rest 37% of the urine samples were from males.

 

Table No.2-Symptoms in Patients

Symptoms

Frequency (n)

Fever

143

Dysuria

124

Urgency

87

Abdominal pain

46

Oliguria

12

Fever (143) and Dysuria (124) were the most common symptom associated with the infected patients. The least common symptom encountered was oliguria seen in 12 patients.

 

Table No.3 Day wise analysis

DAY 3

3%

DAY 7

8%

DAY 14

18%

DAY 21

35%

DAY 28

55%

The CAUTI cases were detected from 3rd day of catheterization onwards and increased with the duration of catheterization. The more the number of days of catheterization the more the chances of CAUTI. The relation between the days of catheterization and CAUTI was found to be directly proportional.

 

Table No.4- Isolates Analysis

Isolates

Percentage %

Gram Negative

68.67

Gram Positive

30.67

Candida

0.66

The result of this study shows, majority of isolates were Gram negative isolates 103(68.67%), followed by Gram positive bacteria 46(30.67%) and followed by other like Candida 1(0.66%).) among suspected cases of CAUT

 

Table No.5- Isolates

Isolates

Percentage

E.Coli

25.33

Klebsiella spp

20.00

Enterococci spp

14.66

Staphylococcus aureus

16.00

Candida spp

0.66

Pseudomonas spp

5.33

Acinetobactor spp

6.66

Proteus spp

5.33

Citrobactor spp

6.00

Majority of the isolates were E. coli 38 (25.33% ) followed by Klebsiella. spp 30(20.00%), Enterococci spp. 22(14.66%), Staphylococcus aureus 24(16.00%), Candida spp 1(0.66%), Pseudomonas spp.8(5.33%).

 

Table No.6-Antibiotic sensitivity pattern of Staphylococcus aureus

 

Sensitive

Percentage

Resistant

Percentage %

Cefoxitin

15

62.50%

9

37.50%

Gentamicin

16

66.67%

8

33.33%

Co-trimoxazole

14

58.33%

10

41.67%

Penicillin

11

45.83%

13

54.17%

Clindamycin

22

91.67%

2

8.33%

Linezolid

24

100.00%

0

0%

Teichoplanin

24

100.00%

0

0%

Ciprofloxacin

13

54.17%

11

45.83%

In our study Staphylococcus aureus were 100% sensitive to Linezolid and Teichoplanin , 92% sensitive Clindamycin and 54% resistance to Penicillin and 45% resistance to Ciprofloxacin

 

Table No.7-Antibiotic sensitivity pattern of Enterococcus

 

Sensitive

Percentage

Resistant

Percentage

Penicillin

2

9.09%

20

90.91%

Gentamicin

17

77.27%

5

22.73%

Ciprofloxacin

11

50.00%

11

50.00%

Teicoplanin

22

100.00%

0

0%

Linezolid

22

100.00%

0

0%

Table Shows Enterococcus were 100% sensitive to Linezolid, Teichoplanin and 77% sensitive to Gentamycin. 90% of the organisms were resistant to Penicillin

 

Table No.8-Antibiotic sensitivity pattern of E. coli

 

Sensitive

Percentage

Resistant

Percentage

Amikacin

35

92.10.%

3

7.89%

Gentamicin

24

63.15%

14

36.84%

Ciprofloxacin

18

47.36%

20

52.63%

Norfloxacin

18

47.36%

20

52.63%

Piperacillin

33

86.84%

5

13.15%

Piperacillin- tazobactam

38

100.00%

0

0.0%

Nitrofurantoin

38

100.00

0

0.0%

Cotrimoxazole

15

39.47%

23

60.52%

Cefotaxime

20

52.63%

18

47.36%

Ceftazidime

26

68.42%

12

31.57%

In our study E. coli were 100% sensitive to Piperacillin tazobactum and Nitrofurantoin , 92% to Amikacin ,86.84% to Piperacillin. 60% of the organism were resistant to Cotrimoxazole, 52% were resistant to Ciprofloxacin.

 

Table No.9-Antibiotic sensitivity pattern of Klebsiella

 

Sensitive

Percentage

Resistant

Percentage

Amikacin

26

86.67%

4

13.33%

Gentamicin

16

53.33%

14

46.67%

Ciprofloxacin

15

50.00%

15

50.00%

Norfloxacin

15

50.00%

15

50.00%

Piperacillin

23

76.67%

7

23.33%

Piperacillin-

30

100.00%

0

0.00%

Tazobactam

Nitrofurantoin

30

100.00%

30

100.00%

Cotrimoxazole

12

40.00%

18

60.00%

Cefotaxime

10

33.33%

20

66.67%

Ceftazidime

16

53.33%

14

46.67%

Table shows Klebsiella were 100% sensitive to Piperacillin tazobactum,and Nitrofurantoin, 87% sensitive to Amikacin , 77% to Piperacillin. 67% of the organisms were resistant to Cefotaxime, 60% were resistant to Cotrimoxazole, 50% resistant to Ciprofloxacin.

 

DISCUSSION

Urinary tract infections is the most common nosocomial infections, comprising about 35% of such occurrences in both hospitals and nursing homes.The incidence of CAUTI in our study was found to be 58.58%. In a study conducted by Ramindar sandhu et al(2018)12 it was found to be 10.55%. In another study by Adithya acharya et al (2020) 13 it was found to be 62%. The incidence of CAUTI among males and females in our study was found to be 21.87% and 36.71% respectively. In a study conducted by thindiparembeth et al (2022)14, 17.3% males were positive for CAUTI while 31.9% female developed infection. In a study conducted by sunil kumar d Chavan et al15 males (17.7%) were affected more than females (5.5%).        

 

In a study conducted by Jay Khullar et al (2022)16 the most common organisms isolated were E.coli(52.00%).Enterococcus spp.(20.00%) Pseudomonas spp.(16.00%). Klebsiella pneumoniae (12.00%).Same results were reported by Aditya acharya et al(2020)13,the common organisms isolated were E.coli ( 36.5% ),Klebsiella. Spp (20.6%), Enterococci (11.1%), Pseudomonas spp. ( 9.5%), Acinetobacter (8.0%). Sandhu et al (2018)12, study result shows the most common organisms isolated were E. coli 7 (41.18%), K. pneumoniae 1 (5.88%), Citrobacter freundii

 

The antibiotic sensitivity pattern of these different isolates was as follows-

In our study the common isolate E. coli (n=38). 100% sensitive to Piperacillin tazobactum and Nitrofurantoin 60% of the organism were resistant to Cotrimoxazole, 52% were resistant to Ciprofloxacin. Patil and Patil (2018)17 Showed E coli were sensitive to Tigecycycline, Colistin, Meropenem and Amikacin with significant resistance to Cephalosporin, PipracillinTazobactum and Quinolone.  In our study Staphylococcus aureus(n=24) were 100% sensitive to Linezolid and Teichoplanin,92% to Clindamycin. Sandhu et al (2018)12 results show S.aureus were sensitive to Vancomycin (100.00%), followed by Linezolid (100.00%) and Amikacin (100.00%). In our study Klebsiella pneumoniae (n=30) was 100% sensitive to Piperacillin Tazobactum and Nitrofurantoin, 87% sensitive to Amikacin. In another study by Patil and Patil (2018)17 K.pneumoniae were best sensitive to Colistin, Tigecycline, Meropenem, Imipenem, Aminoglycosides, this study findings are similar to our study findings.

 

CONCLUSION

In conclusion, the objective of this study was to determine the isolates causing CAUTI and their antibiogram in a tertiary care hospital.

 

The results of the study revealed that the most common isolate causing CAUTI in the hospital was Escherichia coli followed by Klebsiella pneumoniae, Staphlococcus aureus, enterococci and Pseudomonas aeruginosa. The study also found that the majority of the isolates were resistant to commonly used antibiotics such as Ampicillin and Ciprofloxacin.

 

The findings of this study have important implications for the management of CAUTI in the hospital setting. The high resistance rates to commonly used antibiotics also highlights the need for more effective and targeted antibiotic therapy in the management of CAUTI.

 

Overall, this study provides valuable information on the epidemiology of CAUTI in a tertiary care hospital and help to guide the development of more effective strategies for preventing and treating this condition.

 

REFERENCES

  1. Behera PK, Panigrahi R, Mishra NS, Tripathy PK. Clinico-microbiological profile of community acquired urinary tract infection in the elderly: a hospital-based study. IOSR Journal of Dental and Medical Sciences 2016;15(11):29- 34.
  2. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001;183(Supplement_1): S1–S4. doi:10.1086/ 318850.
  3. Nicolle LE. Catheter associated urinary tract infections, Nicolle Antimicrobial Resistance and Infection control 2014; 3:23.
  4. Mitchell BG, Fasugba O, Gardner A. Reducing catheter-associated urinary tract infections in hospitals: study protocol for a multisite randomised controlled study. BMJ Open. 2017;7(11):e018871. doi:10.1136/bmjopen-2017-018871.
  5. Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am. 1999;26(4):821–8. doi:10.1016/s0094-0143(05)70222-6.
  6. Avalos Vizcarra I, Hosseini V, Kollmannsberger P, et al. How type 1 fimbriae help Escherichia coli to evade extracellular antibiotics. Sci Rep. 2016;6(1):1–13. doi:10.1038/srep18109.
  7. Hanumantha S, Pilli HPK. Catheter associated urinary tract infection (CAUTI)- Incidence and microbiological profile in a tertiary care hospital in Andhra Pradesh. Indian J Microbiol Res. 2016;3(4):454–7.
  8. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews microbiology. 2015 May;13(5):269.
  9. Anupama Bahuleyan, K. H. Harshan, Geeta Bhai. Microbiological Profile and Antibiogram of Gram-Negative Bacilli Isolated from Catheter Associated Urinary Tract Infections (CAUTI) in Intensive Care Units of a Tertiary CareHospital. 2018December; 1233
  10. G Colle,A.G Fraser, B.P Marmion, A. Simmons. Mackie and Mc Cartney Practical medical Microbiology. Laboratory strategy in diagnosis of infective syndromes. 14th edi ; 2008;85
  11. Clinical and laboratory standards institute, performance standards for antimicrobial susceptibility testing; twenty third informational supplement. CLSI document M100- January, 2014.
  12. Sandhu R, Sayal P, Jakkhar R, Sharma G. Catheterization-associated urinary tract infections: Epidemiology and incidence from tertiary care hospital in Haryana. J Health Res Rev 2018; 5:135-41
  13. Acharya A, Pattnaik D, Jena J. Bacteriology and Antibiotic Sensitivity Pattern of Uropathogens in Patients with Catheter Associated Urinary Tract Infections in a Tertiary Care Hospital, Bhubaneswar, Odisha. EXECUTIVE EDITOR. 2020 Aug;11(8):1
  14. SuShITha TS,         SuSEEla          Catheter Associated           Urinary Tract Infections: A Cross-sectional Study from a Tertiary Care Centre in Kerala, India. Urology. 2022;30(8):27
  15. Sunil Kumar D Chavan, T. Vineetha, Chandrasekaran Kavita. 2020 Bacteriological Profile and antibiogram of Gram Positive Cocci Isolated from Catheter Associated Urinary Tract Infection (CAUTI) in Intensive Care Units of a Tertiary Care Hospital. Int.J.Curr.Microbiol.App.Sci. 9(02): 303-310
  16. Khullar J, Bhasin A, Bath AS, Singal RK. Profile of Urinary Tract Infections in Catheterised Patients in the Critically Ill Population in a Tertiary Care Hospital. Journal, Indian Academy of Clinical Medicine. 2022 Jul;23(3-4).
  17. Patil HV, Patil VC. Clinical, bacteriology profile, and antibiotic sensitivity pattern of Catheter associated Urinary tract infection at tertiary care hospital. Int J Health Sci Res. 2018; 8(1):25-3
Recommended Articles
Research Article Open Access
Association Between Glycemic Gap and Adverse Clinical Outcomes in Diabetic Patients Admitted to the Intensive Care Unit: A Prospective Observational Study in Rural Tertiary Care Centre
2026, Volume-7, Issue 3 : 4776-4779
Research Article Open Access
Spectrum of Cervical Pap Smear According to Bethesda System in Tertiary Care Center of Western Rajasthan
2026, Volume-7, Issue 3 : 4763-4769
Research Article Open Access
Evaluation of Inhalation Device Technique Among Paediatric Asthma Patients Attending A Tertiary Care Hospital in Rajasthan
2026, Volume-7, Issue 3 : 4757-4762
Research Article Open Access
Comparative Clinical and Dermoscopic Findings of Patients With Topical Steroid Damaged Face (TSDF): A Cross-Sectional Observational Study
2026, Volume-7, Issue 3 : 4689-4695
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
9 Views
1 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved